Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Case Review of Patients With Betel Nut-induced Oral Cancer Treated With Pembrolizumab and Cetuximab

NCT07015333 is registered in ClinicalTrials.gov with Commonwealth Healthcare Corporation as lead sponsor.

NCT NCT07015333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07015333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Case Review of Patients With Betel Nut-induced Oral Cancer Treated With Pembrolizumab and Cetuximab
Lead sponsor
Commonwealth Healthcare Corporation
Phase
Observational
Overall status
Completed
Start date
March 1, 2020
Completion date
December 1, 2024
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oral squamous cell carcinoma (oscc)